Descripción
La descripción detallada está siendo preparada por nuestro equipo clínico.
Ensayos Clínicos
NCT07448116
Fase 1
Reclutando
Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.
China
NCT03155620
Fase 2
Activo, no reclutando
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
United States, Australia, Canada, Puerto Rico